Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5451
CALL
Ligand Pharmaceuticals
LGND
$5.92B
| $2.68M | ﹤0.01% |
13,400
+6,000
| +81% | +$1.19M |
2014 Q1
48 quarters
|
|
5452
PUT
Repligen
RGEN
$9.87B
| $2.67M | ﹤0.01% |
22,700
+11,300
| +99% | +$1.58M |
2018 Q2
31 quarters
|
|
5453
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $2.67M | ﹤0.01% |
+52,933
| New | +$2.68M |
2026 Q1
0 quarters
|
|
5454
PUT
Dianthus Therapeutics
DNTH
$4.78B
| $2.67M | ﹤0.01% |
31,800
+21,000
| +194% | +$1.22M |
2025 Q3
2 quarters
|
|
5455
First Trust Indxx Aerospace & Defense ETF
MISL
$707M
| $2.67M | ﹤0.01% |
59,626
+53,238
| +833% | +$2.57M |
2025 Q3
2 quarters
|
|
5456
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.5B
| $2.67M | ﹤0.01% |
+52,033
| New | +$2.69M |
2026 Q1
0 quarters
|
|
5457
CALL
Iovance Biotherapeutics
IOVA
$5.87B
| $2.66M | ﹤0.01% |
759,000
+151,400
| +25% | +$484K |
2019 Q2
27 quarters
|
|
5458
Eton Pharmaceutcials
ETON
$1.57B
| $2.66M | ﹤0.01% |
107,815
+33,671
| +45% | +$589K |
2025 Q4
1 quarter
|
|
5459
CALL
Iridium Communications
IRDM
$5.2B
| $2.66M | ﹤0.01% |
95,900
+45,600
| +91% | +$1.03M |
2013 Q2
51 quarters
|
|
5460
iShares iBonds Dec 2030 Term Treasury ETF
IBTK
$1.09B
| $2.66M | ﹤0.01% |
134,892
+77,704
| +136% | +$1.54M |
2025 Q1
4 quarters
|
|
5461
CALL
Fiverr
FVRR
$305M
| $2.66M | ﹤0.01% |
265,200
+99,500
| +60% | +$1.37M |
2020 Q1
24 quarters
|
|
5462
Vor Biopharma
VOR
$1.08B
| $2.65M | ﹤0.01% |
148,768
-285,126
| -66% | -$4.02M |
2025 Q3
2 quarters
|
|
5463
CALL
Rhythm Pharmaceuticals
RYTM
$6.25B
| $2.65M | ﹤0.01% |
30,500
-7,400
| -20% | -$720K |
2021 Q3
18 quarters
|
|
|
EUAD
5464
PUT
Select STOXX Europe Aerospace & Defense ETF
EUAD
$1.02B
| $2.65M | ﹤0.01% |
65,100
+39,200
| +151% | +$1.77M |
2025 Q2
3 quarters
|
|
5465
CALL
Dropbox
DBX
$7.33B
| $2.65M | ﹤0.01% |
116,700
-29,400
| -20% | -$747K |
2018 Q1
32 quarters
|
|
5466
PUT
Globant
GLOB
$1.54B
| $2.65M | ﹤0.01% |
57,500
-102,100
| -64% | -$5.64M |
2018 Q2
31 quarters
|
|
|
FWDI
5467
Forward Industries Inc
FWDI
$621M
| $2.65M | ﹤0.01% |
598,284
+187,500
| +46% | +$1.07M |
2025 Q3
2 quarters
|
|
5468
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$632M
| $2.65M | ﹤0.01% |
44,453
-28,076
| -39% | -$1.79M |
2023 Q4
9 quarters
|
|
5469
Mitek Systems
MITK
$788M
| $2.65M | ﹤0.01% |
196,046
+4,864
| +3% | +$60.2K |
2025 Q4
1 quarter
|
|
5470
Tronox
TROX
$618M
| $2.65M | ﹤0.01% |
270,891
-433,606
| -62% | -$3.01M |
2014 Q2
47 quarters
|
|
|
OAKG
5471
Oakmark Global Large Cap ETF
OAKG
$36.4M
| $2.65M | ﹤0.01% |
109,114
-51,329
| -32% | -$1.32M |
2025 Q4
1 quarter
|
|
5472
PUT
Lennox International
LII
$12.6B
| $2.65M | ﹤0.01% |
5,700
+300
| +6% | +$154K |
2014 Q2
47 quarters
|
|
5473
Stock Yards Bancorp
SYBT
$2.39B
| $2.64M | ﹤0.01% |
39,879
+5,267
| +15% | +$351K |
2025 Q4
1 quarter
|
|
5474
Fidelity Fundamental Large Cap Value ETF
FFLV
$18.2M
| $2.64M | ﹤0.01% |
105,939
-33,378
| -24% | -$849K |
2025 Q2
3 quarters
|
|
5475
Karat Packaging
KRT
$1.07B
| $2.64M | ﹤0.01% |
94,575
+51,971
| +122% | +$1.31M |
2022 Q4
13 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.